Hopveus
Country: European Union
Language: Dutch
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
13-07-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
natriumoxybaat
Available from:
D&A Pharma
ATC code:
N07BB
INN (International Name):
sodium oxybate
Therapeutic group:
Andere medicijnen voor het zenuwstelsel
Therapeutic area:
Substance Withdrawal Syndrome; Alcohol Abstinence
Therapeutic indications:
Substitution treatment for alcohol dependence within a framework of careful medical supervision along with continuous psychosocial support and social rehabilitation. Treatment should be initiated only in patients resistant to existing interventions or in patients for whom existing therapies are contra-indicated or not recommended.
Authorization status:
geweigerd
